The prescription system in the UK places an immense financial burden on transplant patients who require extensive medication regimens. As a double lung transplant recipient, I am compelled to take over twenty pills a day, a life-sustaining but financially taxing necessity. Unfortunately, the current system requires me to pay for my prescriptions without any designated support, which highlights a systemic issue that urgently needs addressing.

For those of us who have undergone major surgeries and transplants, life-long medication is not an option—it is a requirement. Each month, the cost of medications becomes an overwhelming financial strain. Despite the critical nature of this medication in maintaining our health and livelihood, the system does not offer appropriate financial relief to ease this burden.

In the UK, a single prescription item can cost as much as £9.35, and when these costs accumulate, it crosses into hundreds of pounds each month for transplant patients. Many people in similar situations struggle to sustain this financially. Often, they are faced with the gut-wrenching choice of cutting expenses in other areas just to afford their medications.

We believe that medicine necessary for survival should be accessible to everyone. Introducing subsidies or exemptions for individuals with chronic conditions like those who have undergone transplants can significantly reduce the financial burden. There is precedence for such measures; Wales and Scotland offer free prescriptions, demonstrating a feasible solution.

Therefore, we urge you, Keir Starmer, to advocate for a reform in the prescription payment system. This includes considering the implementation of a subsidy program or exemption for transplant patients in England. Reform is essential not only for individual health but for the humane treatment of those who require daily medication to survive. Please support this initiative to alleviate the economic stress and to enable a livable life for many. Sign this petition to show your support for the necessary reform in prescription policy for transplant recipients in the UK.